NEPH Nephros Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NEPH

Price (delayed)

$3.4

Market cap

$36.91M

P/E Ratio

56.67

Dividend/share

N/A

EPS

$0.06

Enterprise value

$33.86M

?
Relative Growth: Rel. Growth: 43
Relative Strength: Rel. Strength: 28
Relative Valuation: Rel. Valuation: 34
Relative Profitability: Rel. Profitability: 55

Nephros is a leading water technology company in medical and commercial water purification and pathogen detection, headquartered in the USA. Its diverse team of passionate employees are dedicated to advancing ...

Highlights
The company's debt fell by 27% YoY and by 9% QoQ
The revenue has grown by 23% YoY
The company's quick ratio fell by 33% YoY but it rose by 6% QoQ
The EPS has contracted by 45% from the previous quarter and by 25% YoY
NEPH's P/E is 42% above its last 4 quarters average of 39.8
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.nephros.com
Peers: RMTI BSX TMO DHR

Key stats

What are the main financial stats of NEPH

NEPH stock price

How has the Nephros stock price performed over time
Intraday
0.89%
1 week
3.98%
1 month
-10.53%
1 year
-14.57%
YTD
-30.33%
QTD
-4.76%

Financial performance

How have Nephros's revenue and profit performed over time
Revenue
$19.12M
Gross profit
$11.46M
Operating income
$677,000
Net income
$776,000
Gross margin
59.9%
Net margin
4.1%
The operating margin fell by 43% QoQ and by 30% YoY
The company's operating income fell by 41% QoQ and by 12% YoY
The company's net margin fell by 36% QoQ and by 21% YoY
Nephros's net income has decreased by 35% from the previous quarter and by 3.1% YoY

Price vs fundamentals

How does NEPH's price correlate with its fundamentals

Growth

What is Nephros's growth rate over time

Valuation

What is Nephros stock price valuation
P/E
56.67
P/B
3.38
P/S
1.89
EV/EBIT
42.92
EV/EBITDA
37.01
EV/Sales
1.77
The EPS has contracted by 45% from the previous quarter and by 25% YoY
NEPH's P/E is 42% above its last 4 quarters average of 39.8
NEPH's price to book (P/B) is 23% less than its last 4 quarters average of 4.4 but 6% more than its 5-year quarterly average of 3.2
Nephros's equity has increased by 15% YoY and by 4.9% QoQ
The price to sales (P/S) is 24% lower than the last 4 quarters average of 2.5 and 21% lower than the 5-year quarterly average of 2.4
The revenue has grown by 23% YoY

Efficiency

How efficient is Nephros business performance
The ROE has contracted by 37% from the previous quarter and by 18% YoY
Nephros's ROIC has decreased by 37% from the previous quarter but it has increased by 6% YoY
The return on assets has declined by 37% since the previous quarter and by 18% year-on-year
The ROS has contracted by 36% from the previous quarter and by 23% YoY

Dividends

What is NEPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NEPH.

Financial health

How did Nephros financials performed over time
The company's quick ratio fell by 33% YoY but it rose by 6% QoQ
The total liabilities rose by 24% YoY but it fell by 10% QoQ
The company's debt is 91% lower than its equity
The debt to equity has declined by 36% year-on-year and by 10% since the previous quarter
The company's debt fell by 27% YoY and by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.